Cargando…
Clinical review: Biomarkers of acute kidney injury: where are we now?
The recognition that acute kidney injury (AKI) is a significant independent risk factor for morbidity and mortality has resulted in a substantial number of publications over the past 5 years or more. In no small part these have, to a degree, highlighted the inadequacy of conventional markers of rena...
Autores principales: | Ostermann, Marlies, Philips, Barbara J, Forni, Lui G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682238/ https://www.ncbi.nlm.nih.gov/pubmed/23014769 http://dx.doi.org/10.1186/cc11380 |
Ejemplares similares
-
Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?
por: Ostermann, Marlies, et al.
Publicado: (2014) -
Goal-directed therapy and acute kidney injury: as good as it gets?
por: Doyle, James F., et al.
Publicado: (2016) -
Fluid overload and acute kidney injury: cause or consequence?
por: Ostermann, Marlies, et al.
Publicado: (2015) -
Long-term sequelae from acute kidney injury: potential mechanisms for the observed poor renal outcomes
por: Varrier, Matt, et al.
Publicado: (2015) -
What every Intensivist should know about COVID-19 associated acute kidney injury
por: Ostermann, Marlies, et al.
Publicado: (2020)